These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 11349266

  • 1. A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients.
    Wiesner R, Rabkin J, Klintmalm G, McDiarmid S, Langnas A, Punch J, McMaster P, Kalayoglu M, Levy G, Freeman R, Bismuth H, Neuhaus P, Mamelok R, Wang W.
    Liver Transpl; 2001 May; 7(5):442-50. PubMed ID: 11349266
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan 27; 65(2):235-41. PubMed ID: 9458021
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 2001 Apr 27; 71(8):1091-7. PubMed ID: 11374408
    [Abstract] [Full Text] [Related]

  • 4. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr 15; 61(7):1029-37. PubMed ID: 8623181
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
    Sollinger HW.
    Transplantation; 1995 Aug 15; 60(3):225-32. PubMed ID: 7645033
    [Abstract] [Full Text] [Related]

  • 6. Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection.
    Palmer SM, Baz MA, Sanders L, Miralles AP, Lawrence CM, Rea JB, Zander DS, Edwards LJ, Staples ED, Tapson VF, Davis RD.
    Transplantation; 2001 Jun 27; 71(12):1772-6. PubMed ID: 11455257
    [Abstract] [Full Text] [Related]

  • 7. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
    Odorico JS, Pirsch JD, Knechtle SJ, D'Alessandro AM, Sollinger HW.
    Transplantation; 1998 Dec 27; 66(12):1751-9. PubMed ID: 9884272
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil may allow cyclosporine and steroid sparing in de novo heart transplant patients.
    Hamour IM, Lyster HS, Burke MM, Rose ML, Banner NR.
    Transplantation; 2007 Mar 15; 83(5):570-6. PubMed ID: 17353776
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.
    Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C.
    Transplantation; 1997 Jan 15; 63(1):39-47. PubMed ID: 9000658
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.
    Sterneck M, Fischer L, Gahlemann C, Gundlach M, Rogiers X, Broelsch C.
    Ann Transplant; 2000 Jan 15; 5(1):43-6. PubMed ID: 10850611
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trial.
    Ruggenenti P, Cravedi P, Gotti E, Plati A, Marasà M, Sandrini S, Bossini N, Citterio F, Minetti E, Montanaro D, Sabadini E, Tardanico R, Martinetti D, Gaspari F, Villa A, Perna A, Peraro F, Remuzzi G.
    PLoS Med; 2021 Jun 15; 18(6):e1003668. PubMed ID: 34166370
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar 15; 61(5):722-9. PubMed ID: 8607174
    [Abstract] [Full Text] [Related]

  • 13. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Mathew TH.
    Transplantation; 1998 Jun 15; 65(11):1450-4. PubMed ID: 9645801
    [Abstract] [Full Text] [Related]

  • 14. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group.
    Lancet; 1995 May 27; 345(8961):1321-5. PubMed ID: 7752752
    [Abstract] [Full Text] [Related]

  • 15. Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.
    Triemer HL, Pearson TC, Odom KL, Larsen CP.
    Clin Transplant; 2000 Aug 27; 14(4 Pt 2):413-20. PubMed ID: 10946781
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.
    Wagner M, Earley AK, Webster AC, Schmid CH, Balk EM, Uhlig K.
    Cochrane Database Syst Rev; 2015 Dec 03; 2015(12):CD007746. PubMed ID: 26633102
    [Abstract] [Full Text] [Related]

  • 17. Short-term combination of mycophenolate mofetil with cyclosporine as a therapeutic option for renal transplant recipients: A prospective, multicenter, randomized study.
    Sadek S, Medina J, Arias M, Sennesael J, Squifflet JP, Vogt B, Neo Int-05 Study group.
    Transplantation; 2002 Aug 27; 74(4):511-7. PubMed ID: 12352910
    [Abstract] [Full Text] [Related]

  • 18. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
    Johnson C, Ahsan N, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, van Veldhuisen P, Salm K, Tolzman D, Fitzsimmons WE.
    Transplantation; 2000 Mar 15; 69(5):834-41. PubMed ID: 10755536
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
    Pham PT, Pham PC.
    Nephrol Dial Transplant; 2012 Jul 15; 27(7):2965-71. PubMed ID: 22207327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.